Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,281,981 papers from all fields of science
Search
Sign In
Create Free Account
vicriviroc
A piperazine-based CCR5 receptor antagonist with activity against human immunodeficiency virus. Vicriviroc is designed to bind to CCR5 and inhibit…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (2)
Piperazines
Pyrimidines
Narrower (1)
Sch-417690
Vicriviroc Maleate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Differential Use of CCR 5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR 5 Antagonists
T. Henrich
,
Nicolas R P Lewine
,
+6 authors
Daniel R. Kuritzkesa
2012
Corpus ID: 45170186
Timothy J. Henrich, Nicolas R. P. Lewine, Sun-Hee Lee, Suhas S. P. Rao, Reem Berro, Roy M. Gulick, John P. Moore, Athe M. N…
Expand
2011
2011
Identification and Characterization of INCB 9471 , an Allosteric Noncompetitive Small-Molecule Antagonist of C-C Chemokine Receptor 5 with Potent Inhibitory Activity against Monocyte Migration and…
N. Shin
,
K. Solomon
,
+19 authors
R. Newton
2011
Corpus ID: 1471114
C-C chemokine receptor 5 (CCR5) is a clinically proven target for inhibition of HIV-1 infection and a potential target for…
Expand
2010
2010
Gateways to clinical trials.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2010
Corpus ID: 31023199
[¹¹C]RAC; (18)F-Fluoromisonidazole; 89-12; 9-[¹⁸F]Fluoropropyl-(+)-dihydrotetrabenazine; Adalimumab, Adecatumumab, ADMVA, ADXS-11…
Expand
2009
2009
168 Rapamycin enhances the antiviral activity of CCR5 antagonist Vicriviroc
O. Latinovic
2009
Corpus ID: 72542627
2009
2009
Gateways to clinical trials.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2009
Corpus ID: 40344481
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand
2008
2008
Vicriviroc in Treatment-Naive Patients
S. Chimienti
2008
Corpus ID: 78738750
Vicriviroc is an investigational CCR5 inhibitor that seemed promising in industry-funded, phase I clinical trials involving…
Expand
2007
2007
Vicriviroc in Treatment-Experienced Patients: 24-Week Results
C. Hicks
2007
Corpus ID: 74676917
Vicriviroc is one of two CCR5 inhibitors being developed to treat HIV infection. In this phase II study (ACTG 5211…
Expand
Review
2007
Review
2007
CCR5 ANTAGONISTS: COMPARISONOFEFFICACY, SIDEEFFECTS, PHARMACOKINETICSANDINTERACTIONS- REVIEWOFTHELITERATURE
J. Emmelkamp
,
J. Rockstroh
2007
Corpus ID: 58423565
In the context of emerging resistance to antiretroviral agents in HIV medicine, the development of new drugs classes with a novel…
Expand
2006
2006
Report from the 13th retrovirus conference. Vicriviroc less effective than efavirenz in treatment-naive patients.
P. Sax
AIDS Clinical Care
2006
Corpus ID: 34414017
2006
2006
Snapshots for May 2006
P. Pegram
,
Charles DeComarmond
,
J. Williamson
2006
Corpus ID: 86661183
s (91, 92, 293). A European group (abstract 33LB) demonstrated in the first randomized controlled trial that active herpes…
Expand